Cytek Biosciences
CTKB
CTKB
152 hedge funds and large institutions have $501M invested in Cytek Biosciences in 2024 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 57 increasing their positions, 42 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
152
Holders Change
+16
Holders Change %
+11.76%
% of All Funds
2.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
57
Reduced
42
Closed
16
Calls
$11K
Puts
–
Net Calls
+$11K
Net Calls Change
+$14K
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
$4.32M |
| 2 |
Millennium Management
New York
|
$5.22M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
$2.53M |
| 4 |
JPMorgan Chase & Co
New York
|
$6.15M |
| 5 |
State Street
Boston,
Massachusetts
|
$29.3M |
